Retinal pigment epithelial tear following intravitreal injection of brolucizumab

Noy Ashkenazy; Caroline R Baumal; Audina M Berrocal

doi:10.4103/ijo.ijo_2665_20

Retinal pigment epithelial tear following intravitreal injection of brolucizumab

Indian J Ophthalmol Case Rep. 2021;1(2):213-214. doi: 10.4103/ijo.ijo_2665_20. Epub 2021 Apr 1.

Authors

Noy Ashkenazy¹, Caroline R Baumal², Audina M Berrocal¹

Affiliations

¹ Department of Ophthalmology, Bascom Palmer Eye Institute, Retina Service, University of Miami Miller School of Medicine, Miami, Florida.
² Department of Ophthalmology, New England Eye Center, Tufts Medical Center, Boston, Massachusetts, USA.

No abstract available

Keywords: Aflibercept; age-related macular degeneration; anti-vascular endothelial growth factor (anti-VEGF); brolucizumab; pigment epithelial detachment; retinal pigment epithelial tear.

Grants and funding

P30 EY014801/EY/NEI NIH HHS/United States